![1]()
News
Weight-related COVID-19 severity starts in normal BMI range, especially in young
May 4, 2021
Increases in BMI, beginning in normal ranges, show a linear link to severe COVID-19 outcomes, independent of obesity-related diseases in younger and Black patients.
![1]()
News
Torsemide vs. furosemide in heart failure patients
May 3, 2021
Does the use of torsemide improve clinical outcomes when compared with furosemide?
![1]()
News
Higher MI shock survival with NCSI protocol: Final results
April 30, 2021
Final results of the National Cardiogenic Shock Initiative show better survival rates in acute MI shock than seen in previous North American studies, but 1-year mortality remains a problem.
News
No link seen between heart inflammation and COVID shots, CDC says
April 29, 2021
“We have not seen a signal and we’ve actually looked intentionally for the signal in the over 200 million doses we’ve given,” says CDC director Rochelle Walensky.
![1]()
News
Being overweight ups risk of severe COVID-19 in hospital
April 29, 2021
This research “adds to the known data on the associations between obesity and severe COVID-19 disease and extends these findings” to patients who are overweight and/or have diabetes.
News
Infective endocarditis from IV drug use tied to hemorrhagic stroke
April 27, 2021
The incidence of patients with IVDU-associated endocarditis increased 630% from 2014 to 2018.
![1]()
News
Efficacy and safety of daily low-dose colchicine after recent MI
April 26, 2021
Can giving low-dose colchicine to patients after a recent myocardial infarction reduce future ischemic cardiovascular events, compared with placebo?
![1]()
News
Lower target LDL-C cuts risk of CV events in ischemic stroke patients
April 23, 2021
Is a target LDL cholesterol (LDL-C) level of less than 70 mg/dL superior to a target LDL-C level of 90-110 mg/dL in prevention of future cardiovascular (CV) events in patients with a prior stroke of atherosclerotic origin or transient ischemic attack (TIA)?
![1]()
News
COVID plus MI confers poor prognosis; 1 in 3 die in hospital
April 22, 2021
National registry data confirm the challenges and uniqueness of patients with STEMI and COVID-19, with atypical symptoms and ‘very high’ in-hospital mortality rates.
![1]()
News
Assessing the efficacy and safety of dapagliflozin in patients with HFrEF
April 22, 2021
Can the use of dapagliflozin, in addition to guideline-directed medical therapy, improve patient-reported outcomes and health-related quality of life in patients with heart failure and reduced ejection fraction (HFrEF)?
